The development of 5-nitroimidazoles for the treatment and prophylaxis of anaerobic bacterial infections.
D000693:Anaerobiosis; D000890:Anti-Infective Agents / Q000138:chemical synthesis*; D001424:Bacterial Infections / Q000188:drug therapy* / Q000517:prevention & control; D055598:Chemical Phenomena; D002621:Chemistry; D006801:Humans; D009593:Nitroimidazoles / Q000138:chemical synthesis* / Q000627:therapeutic use; D010084:Oxidation-Reduction; D013329:Structure-Activity Relationship
D000890:Anti-Infective Agents; D009593:Nitroimidazoles